| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
34 |
| issn |
1776-260X
1776-2596 |
| issueIdentifier |
Suppl 1 |
| pageRange |
S29-34 |
| publicationName |
Targeted Oncology |
| startingPage |
S29 |
| bibliographicCitation |
Gascon P. Presently available biosimilars in hematology-oncology: G-CSF. Targeted Oncology. 2012 Jan 19;7(Suppl 1):29–34. doi: 10.1007/s11523-011-0190-9. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa2e7e114ed58e78a40e12227b1a19c4 |
| date |
2012-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3291849
https://pubmed.ncbi.nlm.nih.gov/22258705
https://doi.org/10.1007/s11523-011-0190-9 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1776-2596
https://portal.issn.org/resource/ISSN/1776-260X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35747 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Presently available biosimilars in hematology-oncology: G-CSF |
| discusses |
http://id.nlm.nih.gov/mesh/M0557421
http://id.nlm.nih.gov/mesh/M0024696 |